Assignee
KRONOS BIO INC
US·9 granted patents·5 pending applications·8 citations·filing 2018–2025
Top patents by PatentIndex Score
14 records- 0191US10842803B2Imidazopyridines Syk inhibitorsKRONOS BIO INC·Filed 2018·Granted Nov 24, 2020·3 cites·11 claims
- 0287US11517570B2Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amineKRONOS BIO INC·Filed 2020·Granted Dec 6, 2022·1 cites·22 claims
- 0385US12152037B2Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as a Syk inhibitorKRONOS BIO INC·Filed 2022·Granted Nov 26, 2024·1 cites·7 claims
- 0484US12263163B2Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as a Syk inhibitorKRONOS BIO INC·Filed 2022·Granted Apr 1, 2025·0 cites·19 claims
- 0584US11155560B2Substituted pyrazolo[1,5-a]pyrimidines for modulating CDK9 activityKRONOS BIO INC·Filed 2019·Granted Oct 26, 2021·1 cites·4 claims
- 0679US11339168B2Crystalline forms of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as Syk inhibitorsKRONOS BIO INC·Filed 2020·Granted May 24, 2022·1 cites·4 claims
- 0778US2024132506A1Compounds, compositions, and methods for modulating cdk9 activityKRONOS BIO INC·Filed 2023·Application pending·0 cites
- 0875US11845754B2Substituted pyrazolo[1,5-a]pyrimidines for modulating CDK9 activityKRONOS BIO INC·Filed 2021·Granted Dec 19, 2023·0 cites·11 claims
- 0974US2025313566A1CRYSTALLINE FORMS OF 6-(6-AMINOPYRAZIN-2-YL)-N-(4-(4-(OXETAN-3-YL)PIPERAZIN-1-YL)PHENYL)IMIDAZO[l,2-a]PYRAZIN-8-AMINE AS SYK INHIBITORSKRONOS BIO INC·Filed 2024·Application pending·0 cites
- 1073US11384082B2Hydrates of polymorphs of 6-(1H-indazol-6-YL)-N-(4-morpholinophenyl)-2,3-dihydroimidazo[1,2-A]pyrazin-8-amine bisemsylate as Syk inhibitorsKRONOS BIO INC·Filed 2018·Granted Jul 12, 2022·1 cites·21 claims
- 1165US12122781B2Hydrates of polymorphs of 6-(1H-indazol-6-yl)-N-(4-morpholinophenyl)-2,3-dihydroimidazo[1,2-a]pyrazin-8-amine bis-mesylate as Syk inhibitorsKRONOS BIO INC·Filed 2022·Granted Oct 22, 2024·0 cites·19 claims
- 1258US2025059193A1Polymorphic and salt forms of (1s,3s)-n1-(5-(pentan-3-yl)pyrazolo[1,5-a]pyrimidin-7-yl) cyclopentane-1,3-diamineKRONOS BIO INC·Filed 2022·Application pending·0 cites
- 1353US2025188084A1Compounds and methods for modulating cdk9 activityKRONOS BIO INC·Filed 2021·Application pending·0 cites
- 1449US2026028344A1Crystalline forms of lanraplenib and methods of making and using the sameKRONOS BIO INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when KRONOS BIO INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →